SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-136867
Filing Date
2022-05-02
Accepted
2022-05-02 16:36:56
Documents
6
Period of Report
2022-06-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A d296110ddef14a.htm DEF 14A 1373769
2 GRAPHIC g296110g10v55.jpg GRAPHIC 30818
3 GRAPHIC g296110g11i11.jpg GRAPHIC 233912
4 GRAPHIC g296110g16f81.jpg GRAPHIC 24487
5 GRAPHIC g296110g22i22.jpg GRAPHIC 282644
6 GRAPHIC g296110g69b62.jpg GRAPHIC 37433
  Complete submission text file 0001193125-22-136867.txt   2208519
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-14956 | Film No.: 22882557
SIC: 2834 Pharmaceutical Preparations